Literature DB >> 29275311

Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.

Salvatore Siracusano1, Carolina D'Elia2, Maria Angela Cerruto1, Omar Saleh3, Sergio Serni3, Mauro Gacci3, Stefano Ciciliato4, Alchiede Simonato5, Antonio Porcaro1, Vincenzo DE Marco1, Renato Talamini6, Laura Toffoli4, Francesco Visalli4, Mauro Niero7, Cristina Lonardi7, Ciro Imbimbo8, Paolo Verze8, Vincenzo Mirone8, Marco Racioppi9, Massimo Iafrate10, Giovanni Cacciamani1, Davide DE Marchi1, Pierfrancesco Bassi9, Walter Artibani1.   

Abstract

BACKGROUND/AIM: Studies comparing health-related quality of life (HR-QoL) between patients who underwent radical cystectomy (RC) and those who underwent a different form of urinary diversion has not reached yet univocal and reliable conclusions. The aim of our study was to evaluate bladder-specific long-term HR-QoL after radical cystectomy and ileal conduit. PATIENTS AND METHODS: A multicenter study was carried out on 145 consecutive patients (112 males and 33 females) undergoing RC and ileal conduit (IC). HR-QoL assessment was conducted using Italian versions of European Organisation for Research and Treatment of Cancer QLQ-C30 and EORTC BLM-30 questionnaires.
RESULTS: Our data showed that women who underwent IC presented greater problems than men in cognitive functioning (mean score±SD: 77.3±27.9 vs. 87.8±18.6) as well in future perspective (score: 42.4±34.4 vs. 21.9±24.6). Nevertheless, men undergoing IC had more problems in sexual functioning than women (score: 23.3±24.5 vs. 7.0±20.3) (all p<0.05).
CONCLUSION: In our series, female patients presented a greater burden than male patients in cognitive functioning as well in future perspective, but lower concerns with regard to sexual function. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Bladder cancer; ileal conduit; orthotopic neobladder; quality of life; radical cystectomy

Mesh:

Year:  2018        PMID: 29275311      PMCID: PMC5892632          DOI: 10.21873/invivo.11216

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

1.  Quality of life in long-term survivors of bladder cancer.

Authors:  Veerasathpurush Allareddy; Julianna Kennedy; Michele M West; Badrinath R Konety
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

2.  A body image scale for use with cancer patients.

Authors:  P Hopwood; I Fletcher; A Lee; S Al Ghazal
Journal:  Eur J Cancer       Date:  2001-01       Impact factor: 9.162

Review 3.  Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit.

Authors:  M A Cerruto; C D'Elia; S Siracusano; X Gedeshi; A Mariotto; M Iafrate; M Niero; C Lonardi; P Bassi; E Belgrano; C Imbimbo; M Racioppi; R Talamini; S Ciciliato; L Toffoli; M Rizzo; F Visalli; P Verze; W Artibani
Journal:  Eur J Surg Oncol       Date:  2015-11-09       Impact factor: 4.424

Review 4.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Authors:  Marko Babjuk; Maximilian Burger; Richard Zigeuner; Shahrokh F Shariat; Bas W G van Rhijn; Eva Compérat; Richard J Sylvester; Eero Kaasinen; Andreas Böhle; Joan Palou Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

5.  Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.

Authors:  Kimberley S Mak; Angela B Smith; Alec Eidelman; Rebecca Clayman; Andrzej Niemierko; Jed-Sian Cheng; Jonathan Matthews; Michael R Drumm; Matthew E Nielsen; Adam S Feldman; Richard J Lee; Anthony L Zietman; Ronald C Chen; William U Shipley; Matthew I Milowsky; Jason A Efstathiou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-08-24       Impact factor: 7.038

Review 6.  A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer.

Authors:  Linda S Yang; Bernard L Shan; Leonard L Shan; Peter Chin; Spencer Murray; Nariman Ahmadi; Akshat Saxena
Journal:  Surg Oncol       Date:  2016-06-07       Impact factor: 3.279

7.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

8.  When should quality of life be measured after radical cystectomy?

Authors:  Haluk Kulaksizoglu; Gökhan Toktas; Isinn Baral Kulaksizoglu; Erdogan Aglamis; Erdinç Unlüer
Journal:  Eur Urol       Date:  2002-10       Impact factor: 20.096

Review 9.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Authors:  Sebastien Antoni; Jacques Ferlay; Isabelle Soerjomataram; Ariana Znaor; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

10.  Modified S-pouch neobladder vs ileal conduit and a matched control population: a quality-of-life survey.

Authors:  Vassilis Protogerou; Maria Moschou; Nikos Antoniou; John Varkarakis; Aris Bamias; Charalambos Deliveliotis
Journal:  BJU Int       Date:  2004-08       Impact factor: 5.588

View more
  2 in total

1.  Vaginal Complications after Radical Cystectomy for Bladder Cancer: A Systematic Review.

Authors:  Lee A Richter; Jillian Egan; Emily C Alagha; Victoria L Handa
Journal:  Urology       Date:  2021-07-17       Impact factor: 2.649

2.  Quality-of-Life Outcomes in Female Patients With Ileal Conduit or Orthotopic Neobladder Urinary Diversion: 6-Month Results of a Multicenter Prospective Study.

Authors:  Salvatore Siracusano; Agustina Zaka; Pierfrancesco Bassi; Paolo Gontero; Ettore Mearini; Ciro Imbimbo; Alchiede Simonato; Fabrizio Dal Moro; Gianluca Giannarini; Claudio Valotto; Francesco Montorsi; Renzo Colombo; Francesco Porpiglia; Riccardo Bartoletti; Marco Vella; Andrea Minervini; Antonio Benito Porcaro; Federico Romantini; Carlo Vicentini; Renato Talamini; Vincenzo Ficarra; Cristina Lonardi
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.